TDOC Earnings Date: Feb 24, 2027 (Estimated) — Teladoc Health, Inc.
NYSE · Healthcare · Health Information Services
Updated
When is TDOC's next earnings date?
Teladoc Health, Inc. (TDOC) is expected to report Q4 2026 earnings on Wednesday, February 24, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.11 on revenue of $602.9M.
How did TDOC do in its last earnings report?
In its most recent report on Oct 28, 2026 (Q3 2026), Teladoc Health, Inc. posted EPS of -$0.15 versus the -$0.22 estimate, a beat of 31.0%. Revenue was $605.1M against a $588.1M estimate. The stock's 1-day post-earnings move was +26.9%.
How much does TDOC stock move after earnings?
TDOC beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.0% (up or down) in the day after earnings.
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
🤖 AI Earnings Analysis
Teladoc’s Q3 beat—$605M revenue and a $0.15 loss per share versus estimates—offers little comfort as revenue fell 3.4% year over year and losses persist. Healthcare virtual-care growth remains challenged; full-year revenue guidance is $2.4B.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-28 | Q3 2026 | -0.22 | -0.15 | +30.96% | $605.1M | ✅ Beat | +26.89% | — | — |
| 2026-07-29 | Q2 2026 | -0.24 | -0.21 | +12.50% | $606.9M | ✅ Beat | -28.32% | -24.51% | -30.72% |
| 2026-04-29 | Q1 2026 | -0.37 | -0.36 | +2.70% | $613.8M | ✅ Beat | +1.85% | +14.29% | +27.90% |
| 2026-02-25 | Q4 2025 | -0.21 | -0.14 | +33.33% | $642.3M | ✅ Beat | +15.05% | +10.32% | +18.71% |
| 2025-10-29 | Q3 2025 | -0.24 | -0.20 | +16.67% | $626.4M | ✅ Beat | +6.20% | -2.07% | -7.78% |
| 2025-07-29 | Q2 2025 | -0.29 | -0.19 | +34.48% | $631.9M | ✅ Beat | -1.73% | -7.57% | +2.79% |
| 2025-04-30 | Q1 2025 | -0.36 | -0.19 | +47.22% | $629.4M | ✅ Beat | -2.78% | -4.59% | -3.76% |
| 2025-02-26 | Q4 2024 | -0.29 | -0.28 | +3.45% | $640.5M | ✅ Beat | -13.56% | -17.83% | -22.11% |
Showing last 8 quarters.
Revenue by segment & region
By region
Q3 FY26 · $605.1M total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 80.8% | $489.2M | -4.0% | $525.0M | $519.7M | $509.8M | $517.3M |
| Non-US | 19.2% | $115.9M | -0.7% | $104.4M | $112.2M | $116.7M | $125.0M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.